Balanced news tone
News Sentiment
LXRX sentiment intelligence
Lexicon Pharmaceuticals Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Price is moving more forcefully than the current news tone suggests.
79/100 classification confidence.
directly relevant articles
high-authority source matches
-4.3% over one week, +15.6% over four weeks, trend active, and materially above fair value.
What Lexicon Pharmaceuticals (LXRX)'s Broad Russell Index Inclusion Means For Shareholders
Market Reaction
Price moving ahead of tone
Price is moving more forcefully than the current news tone suggests.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
How The Lexicon Pharmaceuticals (LXRX) Investment Narrative Is Evolving With Quiet Analyst Updates
- Tone
- Neutral 50/100
- Event
- Analyst action
- Published
- 04 Jun 2026 07:00
- Source
- Market source
Lexicon Pharmaceuticals (LXRX) director converts 89,312 RSUs into common stock holdings
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 04 Jun 2026 07:00
- Source
- Stock Titan
Lexicon to Present Data at the American Diabetes Association (ADA) 2026 Scientific Sessions
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 03 Jun 2026 12:00
- Source
- GlobeNewswire
New Type 1 diabetes drug data from Lexicon at ADA 2026 meeting
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 03 Jun 2026 07:00
- Source
- Stock Titan
Lexicon (LXRX) Q1 2026 Earnings Transcript
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 01 Jun 2026 20:40
- Source
- Motley Fool
Lexicon Pharmaceuticals to Present at the 2026 Jefferies Global Healthcare Conference
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 28 May 2026 12:30
- Source
- GlobeNewswire
Lexicon Pharma schedules Jefferies healthcare fireside chat for June 4
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 28 May 2026 07:00
- Source
- Stock Titan
Citi Raises its Price Target on Lexicon Pharmaceuticals (LXRX)
- Tone
- Positive 66/100
- Event
- Analyst action
- Published
- 22 May 2026 07:00
- Source
- Market source
There May Be Reason For Hope In Puma Biotechnology's (NASDAQ:PBYI) Disappointing Earnings
- Tone
- Negative 34/100
- Event
- Earnings
- Published
- 15 May 2026 07:00
- Source
- simplywall.st
Puma Biotechnology's (NASDAQ:PBYI) Conservative Accounting Might Explain Soft Earnings
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 14 May 2026 07:00
- Source
- Market source
Lexicon Pharmaceuticals to Present at the 4th Annual H.C. Wainwright BioConnect Investor Conference
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 12 May 2026 12:30
- Source
- GlobeNewswire
Lexicon Pharmaceuticals (LXRX) Is Up 46.1% After Revenue Surges And Loss Narrows Sharply – What's Changed
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 12 May 2026 07:00
- Source
- Market source
Fireside chat at Nasdaq HQ: Lexicon joins H.C. Wainwright investor event May 19
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 12 May 2026 07:00
- Source
- Stock Titan
Puma Biotechnology, Inc. (NASDAQ:PBYI) Analysts Are Pretty Bullish On The Stock After Recent Results
- Tone
- Positive 66/100
- Event
- Earnings
- Published
- 11 May 2026 07:00
- Source
- simplywall.st
Earnings Update: Here's Why Analysts Just Lifted Their Puma Biotechnology, Inc. (NASDAQ:PBYI) Price Target To US$5.00
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 11 May 2026 07:00
- Source
- Market source
Lexicon (LXRX) Reports $21.1M Q1 Revenue Driven by Novo Nordisk Milestones
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 09 May 2026 07:00
- Source
- Market source
Lexicon Pharmaceuticals Q1 Earnings Call Highlights
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 08 May 2026 07:00
- Source
- Market source
Lexicon Pharmaceuticals (LXRX) Quarterly Revenue Drop Reinforces Concerns Over Persistent Losses
- Tone
- Negative 34/100
- Event
- Earnings
- Published
- 08 May 2026 07:00
- Source
- simplywall.st
Lexicon targets diabetes filing, heart trial, obesity study milestones
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 07 May 2026 07:00
- Source
- Stock Titan
Lexicon Pharmaceuticals (LXRX) Reports Break-Even Earnings for Q1
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 07 May 2026 07:00
- Source
- Market source
Lexicon schedules May 7 webcast to discuss its Q1 results
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 30 Apr 2026 07:00
- Source
- Stock Titan
Q4 Earnings Highlights: Regeneron (NASDAQ:REGN) Vs The Rest Of The Biotechnology Stocks
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 25 Apr 2026 07:00
- Source
- Market source
Lexicon Pharmaceuticals (LXRX) to Present Phase 2b Pilavapadin Data
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 23 Apr 2026 07:00
- Source
- Market source
Biotechnology Stocks Q3 Results: Benchmarking Natera (NASDAQ:NTRA)
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 21 Apr 2026 07:00
- Source
- Market source
How The Lexicon Pharmaceuticals (LXRX) Story Is Shifting Around Pilavapadin And Valuation Assumptions
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 06 Apr 2026 07:00
- Source
- Market source
How The Lexicon Pharmaceuticals (LXRX) Story Is Shifting With Fine Tuned Targets And Trials
- Tone
- Neutral 50/100
- Event
- Regulatory and legal
- Published
- 22 Feb 2026 08:00
- Source
- Market source
Lexicon Pharmaceuticals Completes Public Offering of Common Stock and Concurrent Private Placement
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 06 Feb 2026 08:00
- Source
- Quiver Quantitative
Lexicon Pharmaceuticals Announces Pricing of $41.6 Million Public Offering of Common Stock
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 30 Jan 2026 08:00
- Source
- Quiver Quantitative
Lexicon Pharmaceuticals prices public offering at $1.30 per share
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 30 Jan 2026 08:00
- Source
- Investing.com
Lexicon Pharmaceuticals Rings the Nasdaq Stock Market Closing Bell
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 27 Jan 2026 08:00
- Source
- Nasdaq